Skip to main content
Erschienen in: Acta Neurochirurgica 7/2021

Open Access 02.04.2021 | Original Article - Brain trauma

Risk factors for need of reoperation in bilateral chronic subdural haematomas

verfasst von: Shaian Zolfaghari, Jiri Bartek Jr, Felix Djärf, San-San Wong, Isabelle Strom, Nils Ståhl, Asgeir S. Jakola, Henrietta Nittby Redebrandt

Erschienen in: Acta Neurochirurgica | Ausgabe 7/2021

Abstract

Background

Chronic subdural haematoma (CSDH) is one of the most common neurosurgical diseases. A subtype of CSDH is bilateral chronic subdural haematoma (bCSDH) which represents 20–25% of patients with CSDH and has a higher recurrence rate. There is no clear consensus on how bCSDH should be treated regarding upfront unilateral- or bilateral evacuation of both haematomas. The purpose of this study was to identify risk factors associated with reoperation of bCSDH.

Methods

A total of 326 patients with radiological evidence of bCSDH were included in this retrospective cohort study where 133 (40.8%) patients underwent primary bilateral evacuation and 193 (59.2%) primary unilateral evacuation. The two centres operated using different surgical approaches. Analyses were performed to identify risk factors associated with reoperation of bCSDH. Reoperation rate was defined as reoperation of CSDH on either side of the hemisphere within 3 months after primary evacuation.

Results

The cohort had a total reoperation rate of 26.4%. Patients which underwent unilateral evacuation had a reoperation rate of 32.1%, and the bilateral group had a reoperation rate of 18.0% (p=0.005). Multivariable logistic regression identified unilateral evacuation (OR 1.91, p=0.022) and complications according to Ibanez (OR 2.20, p=0.032) to be associated with the need of reoperation of bCSDH. One-burr hole craniostomy with active subgaleal drain was primarily performed in bilateral approach (69.4%) whereas patients operated with minicraniotomy with passive subdural drain were primarily operated by unilateral evacuation of the larger symptomatic side (92.8%).

Conclusions

Unilateral evacuation of bCSDH was associated with a higher risk for reoperation than upfront bilateral evacuations in this study. There is a need to further discuss the criteria for uni- or bilateral evacuation since patients are treated differently at different centres.
Hinweise
This article is part of the Topical Collection on Brain trauma

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CSDH
Chronic subdural haematoma
bCSDH
Bilateral chronic subdural haematoma
1-BHC
1-Burr hole craniostomy

Introduction

Chronic subdural haematoma (CSDH) is a common neurosurgical condition with an incidence of 8 to 14 per 100,000 person-years [13]. Common risk factors for CSDH are falls, alcohol abuse, anticoagulant therapy, advanced age and brain atrophy [13]. Furthermore, it has also been shown that antiplatelet therapy alone and in combination with anticoagulant therapy also increases the risk for CSDH [11, 12]. The incidence of CSDH is expected to significantly rise in the coming decades; thus, research concerning the clinical management of CSDHs is of importance [1, 4]. The recurrence rate of CSDH is commonly accepted to be around 10–20% with wide variety between results reported from different centres [5, 7]. The perioperative management of CSDHs varies widely between different centres with the major differences in surgical techniques and types of postoperative drainage [22].
A subtype of CSDHs is bilateral chronic subdural haematoma (bCSDH). There is no consensus on how bCSDHs should be managed due to lack of evidence. Depending on factors such as haematoma size and lateralisation of symptoms, certain centres or neurosurgeons will opt to primarily evacuate unilaterally, while other centres will opt to primarily evacuate bilaterally. Thus, not only resulting in the question of whether the patient should be evacuated upfront with unilateral or bilateral approach, but also if the condition should be treated with one procedure or if two procedures will be required in the case of initial unilateral evacuation.
There has recently been a surge in research concerning bCSDH in order to find evidence for standardised treatment guidelines [3, 16, 19, 24]. It has previously been highlighted that bCSDHs themselves are risk factors for recurrence [3, 5, 10, 14]. One recent study found that upfront bilateral evacuation significantly lowered the risk for reoperation and complications [3]. However, there has also been recent data presented indicating that unilateral evacuation of bCSDH can be sufficient as a management strategy [16]. Overall, there is currently conflicting evidence in literature as to the surgical management of bCSDH.
The aim was to determine risk factors for the need of reoperation of bCSDH with data from two neurosurgical departments in Sweden, with emphasis on the effect of unilateral versus bilateral evacuation.

Methods and materials

Study cohort

The following retrospective study cohort included patients with radiological evidence of bCSDHs that underwent surgical evacuation from two anonymised university hospitals in Sweden represented as hospital A and hospital B. The patients at hospital A were operated between 2012 and 2016, and the patients from hospital B were operated between 2006 and 2014. The same surgical protocols were routinely used in the respective centres during the study time periods without any alterations during the study time periods. All included patients were over the age of 18. Patients with unilateral CSDH, cerebral shunts, simultaneous intracranial haemorrhages and patients with permanent residency outside of Sweden were excluded from the cohort. A total of 326 patients were included in this retrospective study cohort.

Surgical techniques

Patients were operated and managed with the following surgical techniques denoted as method 1 and 2. Note that a minority of the patients included were operated with alternative techniques. Method 1 (i) was the standard surgical technique for evacuation of CSDH at hospital A. Method 2 (ii) was the standard surgical technique for evacuation of CSDH at hospital B.
i.
Two or three burr-holes combined into a minicraniotomy: the haematoma was evacuated with irrigation after which a passive drain was placed in the subdural space for 24 h.
 
ii.
Singular burr-hole: the haematoma was evacuated with irrigation after which an active (suction) drain was placed in the subgaleal space for 24 h [22].
 

Variables

To assess baseline characteristics for the study cohort, the following variables were included: age, hospital (A or B), gender and Charlson Comorbidity Index (CCI) variables (index which predicts mortality based on weighted comorbidities) [17]. Furthermore, preoperative neurological deficits, presenting Glasgow Coma Scale (GCS) score, antithrombotic medication and anticoagulant medication (vitamin K antagonist and novel oral anticoagulants (NOAC)) were registered. Patients were examined as to thrombocytes, INR, APTT and, in some cases, ROTEM and/or Multiplate. Patients with abnormal test values indicative of coagulopathy were optimised prior to surgery. All patients were examined with a preoperative computed tomography (CT) of the head.
The following surgery-related variables were gathered: midline shift, haematoma diameter on the axial plane on both sides, haematoma density on head-CT (hyperdense, isodense, hypodense and mixed densities), primary surgical evacuated side (unilaterally or bilaterally), surgical procedure performed (craniotomy, 1-burr hole craniostomy (1-BHC), minicraniotomy or other surgical method) and drainage system (active subgaleal drain or passive subdural drain).
Reoperation was defined as reoperation of CSDH on either side of the hemisphere within 3 months after primary evacuation, to account for both haematoma recurrence on the previously operated side and the possible need to operate the contralateral side to the one previously operated. Complications were registered according to Landriel Ibañez (Classification system for complications after neurosurgical procedures) [15]. Reoperation was not registered as a complication in our study.

Statistical analysis

All statistical analyses were performed using IBM SPSS Statistics for Windows, version 25.0, Armonk, New York, IBM Corporation. Univariate (independent samples t test), bivariable (chi-squared and Fisher’s exact test) and multivariable analyses were performed to determine if any of the studied variables were associated with an increased reoperation rate when comparing bilateral and unilateral surgical approach. Odds ratio (OR) for Fisher’s exact test was calculated within a 95% confidence interval. Multivariable logistical regression model with forward selection was used in this study. In the final multivariable models, we only included variables that yielded a p value of < .25 in univariate or bivariable analyses. The included independent variables were tested for multicollinearity by analysing variance inflation factor (VIF); a conservative cut-off for multicollinearity was set at a VIF value of over 2.5. Alpha level of significance was defined as p value < .05 in all other analyses.

Results

Baseline demographics

In total, 326 patients met the inclusion criteria for study participation and were included. All 326 patients had radiological evidence of bCSDH. Out of the 326 included patients, 133 (40.8%) underwent primary bilateral evacuation and 193 (59.2%) bCSDH patients underwent primary unilateral evacuation (Tables 1 and 2). Patients undergoing unilateral evacuations had a mean midline shift of 5.3 mm while bilateral evacuations had a mean midline shift of 3.5 mm (p=0.001, independent samples t test).
Table 1
Baseline characteristics of patients with bCSDH. Variables are stratified for unilateral and bilateral evacuation
Variable, No. (%)
Unilateral evacuation N=193
No. (%)
Bilateral evacuation, N=133
No. (%)
Hospital
Hospital A, n=153 (46.9)
140 (72.5)
13 (9.8)
Hospital B, n=173 (53.1)
53 (27.5)
120 (90.2)
Male, n=247 (75.8)
136 (70.5)
111 (83.5)
Mean age (years) ± SD
75.2 ± 10.9
74.3 ± 10.1
Charlson Comorbidity Index
Score over 1, n=123 (37.7)
70 (36.3)
53 (39.8)
Antithrombotic treatment, n=68 (20.9)
38 (19.7)
30 (22.6)
Anticoagulation treatment, n=68 (20.9)
44 (22.8)
24 (18.0)
Symptoms at presentation (note that patients often had more than one presenting symptom)
Gait disturbance and falls
127 (65.8)
69 (51.8)
Limb weakness
46 (23.8)
41 (30.8)
Headache
34 (17.6)
50 (37.5)
Speech impairment
38 (19.7)
18 (13.5)
Mental deterioration
23 (11.9)
30 (22.6)
Acute confusion
15 (7.8)
16 (12.0)
Vomiting
11 (5.7)
8 (6.0)
Seizure
7 (3.6)
4 (3.0)
Incontinence
5 (2.6)
3 (2.3)
Visual disturbance
5 (2.6)
2 (1.5)
SD standard deviation
Table 2
Surgical and outcome data of bCSDH patients. The data in the following table is stratified for unilateral and bilateral evacuation
Factor
No. (%)
Unilateral evacuation N=193
No. (%)
Bilateral evacuation N=133
No. (%)
Mean midline shift (mm) ± SDa
5.3 ± 4.0
3.5 ± 2.9
Mean haematoma diameter (mm) ± SD
Right side
15.7 ± 7.2
15.9 ± 5.4
Left side
16.7 ± 6.9
15.5 ± 5.4
Median GCS score
15
15
CT hematoma densityb
Hyperdense
26 (19.7)
21 (16.9)
Isodense
65 (49.2)
60 (48.4)
Hypodense
36 (27.3)
37 (29.8)
Mixed
5 (3.8)
6 (4.9)
Surgical procedure
1-Burr hole craniostomy with active subgaleal drain, n=173 (53.1)
53 (27.5)
120 (90.2)
Minicraniotomy with passive subdural drain, n=138 (42.3)
128 (66.3)
10 (7.5)
Other surgical methodc, n=15 (4.6)
12 (6.2)
3 (2.3)
Mean time with drainage system (days)a
1.07 ± 0.31
1.02 ± 0.19
Reoperated within 3 months after primary evacuation, n=86 (26.4)
62 (32.1)
24 (18.0)
Complications according to Ibañez, n=54 (16.6)
43 (22.3)
11 (8.3)
Grade Ia: Complication requiring no drug treatment
10 (5.2)
3 (2.2)
Grade Ib: Complication requiring drug treatment
12 (6.2)
1 (0.8)
Grade IIa: Complication requiring intervention without general anaesthesia
13 (6.7)
1 (0.8)
Grade IIb: Complication requiring intervention with general anaesthesia
4 (2.1)
2 (1.5)
Grade IIIa: Complication involving single organ failure and ICU care.
1 (0.5)
1 (0.8)
Grade IV: Complication resulting in death
3 (1.6)
3 (2.2)
aSD standard deviation
bData could only be retrieved for 256 patients out of 326.
cOther surgical methods consisted of craniotomy and twist-drill craniostomy

Univariate analysis of complications associated with unilateral or bilateral evacuation

Complications according to Ibañez were dichotomised into a simplified categorical variable containing patients which had experienced a complication and those that did not. Complications graded as Ia, thus those that did not require any treatment, were not included in this variable as they were deemed trivial. Complications were found to be significantly associated with unilateral approach. (p=0.001, Mann-Whitney).

Univariate analysis of factors associated with reoperation of bCSDH.

Univariate analysis was performed on potential factors associated with reoperation of bCSDH which are summarised in Table 3.
Table 3
Univariable analysis of potential factors associated with the retreatment of bCSDH (n=326). Cut-off for significance was set to p < .25, variables which met the significance level were candidates for inclusion in the final multivariable model
Variable
No reoperation
Reoperation
p value
CI 95%
Age in years, mean ± SD
74.75 ± 10.76
75.14 ± 10.13
0.770
−3.011, 2.232
Male
177 (71.7)
70 (28.3)
0.187
0.842, 2.879
CCI score over 1, n (%)
97 (78.9)
26 (21.1)
0.119
0.377, 1.083
Antithrombotic use, n (%)
53 (77.9)
15 (22.1)
0.440
0.395, 1.407
Anticoagulation use, n (%)
51 (75.0)
17 (25.0)
0.877
0.494, 1.688
Midline shift (mm), mean ± SD
4.61 ± 3.63
4.35 ± 3.90
0.569
−0.656, 1.193
Surgically evacuated side—unilateral, n (%)
131 (67.9)
62 (32.1)
0.005
1.174, 2.699
Surgical procedure—Minicraniotomy with passive subdural draina, n (%)
87 (63.0)
51 (37.0)
0.001
1.853, 5.422
Time with drainage system (days), mean ± SD
1.03 ± 0.21
1.09 ± 0.40
0.127
−0.121, 0.015
Complications (not including repeated evacuation of CSDH on either side), n (%)
22 (53.7)
19 (46.3)
0.004
1.435, 5.503
SD standard deviation
a15 cases were excluded due to surgical evacuation with craniotomy and twist-drill craniostomy
Surgical procedure was found to be statistically significant when comparing the two surgical techniques with reoperation within 3 months (p<0.001, Fisher’s exact test, OR CI 95% 1.853–5.422). Complications according to Ibañez were dichotomised into a simplified categorical variable containing patients which had experienced a complication and those that did not. Complications graded as Ibañez Ia were not included in this variable as they were deemed trivial. Univariate analysis of complications with reoperation found a significantly higher rate of complications in patients that were reoperated within 3 months (p=0.004, Fisher’s exact test).
In our study population, we found a reoperation rate of 26.4% within 3 months of primary surgical evacuation. Patients which underwent primary bilateral evacuation of the bCSDH had a reoperation rate of 18.0% while patients which underwent primary unilateral evacuation had a reoperation rate of 32.1% (p=0.005, Fisher’s exact test, OR CI 95% 1.174–2.699).

Multivariable analysis of factors associated with reoperation rate

Multivariable logistic regression analysis was performed on variables which had a p value of < .25 in the univariable analyses. Thus gender, CCI score, surgically evacuated side, surgical procedure, time with drainage and complications were included. Forward selection was employed and yielded only surgical procedure as significant. In this model, patients were 3.17 times more likely to be re-operated when operated with minicraniotomy with passive subdural drain (p=0.001, CI 95% 1.838–5.451), and they were for the absolute majority of times operated unilaterally. Correlative measures were calculated, and it was found that the surgical procedure was significantly correlated with the surgical approach, i.e. uni- or bilateral evacuation (Spearman’s ρ=−0.626). Collinearity diagnostics was performed on all the independent variables in the multivariable analysis. The analysis did not indicate presence of multicollinearity (VIF< 1.7 for all independent variables).
Due to the significant correlation between surgical procedure and surgical approach but also skewed data in variable surgical procedure (only n=10 patients underwent bilateral evacuation with minicraniotomy), a second model using forward selection was created where the variable surgical procedure was excluded in the analysis. From this model, complications and surgical approach (uni- or bilateral evacuation) were found to be significant. Patients which underwent unilateral evacuation were 1.91 times more likely to be re-operated (p=0.022, CI 95% 1.097–3.307). Patients which did have complications were 2.20 times more likely to be re-operated (p=0.032, 95% CI 1.070–4.521). Correlation between complications and surgical approach was of no significance (Spearman’s ρ=−0.164), and collinearity diagnostics did not indicate presence of multicollinearity in this model (VIF < 1.1 for all independent variables)

Discussion

In this retrospective cohort study, we observed a significantly higher risk of reoperation of bCSDH when treated with unilateral compared to bilateral haematoma evacuation. Patients with complications graded higher than Ibañez Ia had a higher risk of reoperation. Further, we found that complications graded higher than Ibañez Ia were associated with unilateral evacuation, and the group we previously noted had an increased reoperation rate. In addition, minicraniotomy and subdural drainage had unfavourable results compared to 1-BHC and subgaleal drainage, but due to positive correlation with uni- or bilateral treatment and lack of patients operated bilaterally with minicraniotomy, further elaboration was not possible. Patients who underwent primary unilateral evacuation had a significantly larger midline shift, but the size of the midline shift was not a significant factor contributing to the risk of reoperation. From a clinical point of view, it seems reasonable to perform a unilateral evacuation if one of the chronic subdural haematomas is causing a significant midline shift, but we do not have any data here to support how the individual surgeon was motivating the choice to perform uni- or bilateral evacuation.
Our results are most likely not indicative of a problem with minicraniotomy as surgical technique, but rather pointing to the effect of the choice of primary unilateral and bilateral approach. There’s also evidence pointing to the minicraniotomy having a place in the treatment of recurrent more organised CSDHs [2, 13, 18, 25]. Identical recurrence rates have been described previously in other studies [3, 19]. It is also important to note that intuitively, the reoperation rate of bCSDH will be higher compared to unilateral CSDH since there are two CSDHs. The fact that patients with unilateral treatment more often experience complications may be due to the higher reoperation rate in this group of patients, resulting in more time spent in hospitals. This in turn could be due to more re-operations, each one increasing the risk of getting a complication.
The clinical question concerning whether bCSDH should be unilaterally or bilaterally evacuated has been raised in several studies with varying conclusions. A retrospective Danish study including 291 patients published in 2016 displayed results pointing to a benefit in bilateral evacuation with a number needed to treat of approximately 6.8 [3]. Our study confirms and is in line with the results observed in the Danish study with unilateral evacuation of bCSDH significantly increasing the risk of reoperation. Our study is to our knowledge the largest retrospective study which has investigated bCSDH concerning the reoperation rate with respect to the choice of surgical approach [3, 16, 19].
Recently, a retrospective study including 128 patients points to satisfactory outcomes with primary unilateral evacuation of bCSDH given that certain prerequisites were met such as a smaller asymptomatic contralateral side. The authors also identified thickness of the untreated contralateral haematoma and the degree of reversal of midline shift on postoperative CT to be factors predicting the need of surgical evacuation of the opposite (non-operated) side [14]. Important to note however is that the assessment of midline shift reversal only can be done postoperatively; thus, there are difficulties in employing the strategy in a setting where we wish to identify patients in need of upfront bilateral evacuation in order to avoid multiple unilateral evacuations. A British study was also able to show a symptomatic recurrence rate of 9% in treatment of bCSDH with approximately 78% undergoing bilateral evacuation [6]. The symptomatic recurrence rate for bCSDHs was identical to the symptomatic recurrence rate for unilateral CSDHs in the same study (8.2%). The recurrence rates are noticeably much lower than ours which warrants attention. The study did not report data on haematoma volumes for the included patients, which makes more specific comparisons difficult. The study did however only include symptomatic recurrences and only within 60 days of primary evacuation. In our study, we set the time frame to 90 days and did not specify that the indication for re-operations strictly needed to be clinical symptoms, but rather every patient who needed a re-operation, irrespective of the clinical motivation, was included.
Our study population was properly adjusted in both the unilateral and bilateral groups in regard to the haematoma volumes. Taking this into consideration, there seems to be a critical volume of when a haematoma poses a significant risk of expanding and necessitating surgical evacuation. Guidelines will often point to a radiological criteria diameter of 1.5 cm to indicate the need of surgical evacuation. However, we would suggest consideration of bilateral evacuation even when the contralateral side to the symptomatic lesion is below 1.5 cm with the data in hand from this study.
Some studies have tried to quantify and isolate the volume of the contralateral side to predict the need of bilateral evacuation. Two studies found that contralateral haematomas with a volume consisting of more than 40 cm3 and 37.84 cm3 respectively warranted consideration for bilateral evacuation [19, 21]. As has been previously postulated in several studies, there seems to be a relationship between the two haematomas in bCSDH. It has been intuitively suggested that when performing unilateral evacuation in bCSDH, the decrease in ICP and expansion of the displaced brain could lead to further progress of the smaller CSDH on the non-operated side which would eventually result in the development of symptomatology/neurological deficits. Furthermore, a study was published in 2010 where they observed a significantly slower re-expansion rate of the brain in bCSDH postoperatively compared to unilateral CSDH [14]. It is postulated that the slower brain re-expansion rate allows for shifting of the brain which in turn may result in an increased risk of bridging vein tears; this in turn could explain the higher reoperation rate in bCSDH. This leads to the question of whether it is the reintroduction of the increased subdural space or the active inflammatory cascade reaction that eventually leads to the advancement of the contralateral haematoma [8, 9, 23]. The most likely explanation is that it is a combination of both ‘disease states’, with the contribution of inflammatory reaction causing the continual recruitment and rebleeding by neocapillaries and on the other hand the neurophysiological properties of the brain such as the effect of persistent increased subdural space.
There are also other risk-benefit and socio-economic aspects to consider when evaluating the pro- and cons of uni- vs. bilateral surgery in bCSDH. A potential disadvantage is the increased risk of postoperative pneumocephalus after bilateral reoperation [20]. With bilateral evacuation, there are however several advantages, such as lower cost of upfront bilateral evacuation instead of two separate unilateral procedures as well as less patient-related discomfort.
To our knowledge, this is the largest retrospective study which has analysed risk factors concerning bCSDH with specific emphasis on reoperation. We need clearer indications for bilateral evacuation, such as a minimum established volume on the contralateral side and/or minimum established diameter of the contralateral haematoma. The study is inherently limited by the retrospective design. There are also limitations pertaining to the data quality and dyssynchronous study time periods.

Conclusion

In this retrospective study, unilateral surgical evacuation of bCSDH seemed to be associated with more reoperations than upfront bilateral evacuation. In addition, there was a higher risk of complications in patients which underwent unilateral evacuation compared to bilateral evacuation. Prospective studies in the form of randomised controlled trials could be of value to establish concrete indication(s) for bilateral evacuation.

Declarations

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The following study has been approved by the regional ethics committee on the respective study sites with ethical permit numbers EPN 2017/247 and EPN 2013/591-31/1.
For this type of study, formal consent is not required.

Conflict of interest

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Literatur
1.
Zurück zum Zitat Adhiyaman V, Chattopadhyay I, Irshad F, Curran D, Abraham S (2017) Increasing incidence of chronic subdural haematoma in the elderly. QJM 110(6):375–378PubMed Adhiyaman V, Chattopadhyay I, Irshad F, Curran D, Abraham S (2017) Increasing incidence of chronic subdural haematoma in the elderly. QJM 110(6):375–378PubMed
2.
Zurück zum Zitat Almenawer SA, Farrokhyar F, Hong C, Alhazzani W, Manoranjan B, Yarascavitch B, Arjmand P, Baronia B, Reddy K, Murty N, Singh S (2014) Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients. Ann Surg 259(3):449–457CrossRef Almenawer SA, Farrokhyar F, Hong C, Alhazzani W, Manoranjan B, Yarascavitch B, Arjmand P, Baronia B, Reddy K, Murty N, Singh S (2014) Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients. Ann Surg 259(3):449–457CrossRef
3.
Zurück zum Zitat Andersen-Ranberg NC, Poulsen FR, Bergholt B, Hundsholt T, Fugleholm K (2017) Bilateral chronic subdural hematoma: unilateral or bilateral drainage? J Neurosurg 126(6):1905–1911CrossRef Andersen-Ranberg NC, Poulsen FR, Bergholt B, Hundsholt T, Fugleholm K (2017) Bilateral chronic subdural hematoma: unilateral or bilateral drainage? J Neurosurg 126(6):1905–1911CrossRef
4.
Zurück zum Zitat Balser D, Farooq S, Mehmood T, Reyes M, Samadani U (2015) Actual and projected incidence rates for chronic subdural hematomas in United States veterans administration and civilian populations. J Neurosurg 123(5):1209–1215CrossRef Balser D, Farooq S, Mehmood T, Reyes M, Samadani U (2015) Actual and projected incidence rates for chronic subdural hematomas in United States veterans administration and civilian populations. J Neurosurg 123(5):1209–1215CrossRef
5.
Zurück zum Zitat Bartek J Jr, Sjåvik K, Kristiansson H, Ståhl F, Fornbe I, Förander P, Jakola AS (2017) Predictors of recurrence and complications after chronic subdural hematoma surgery: a population-based study. World Neurosurg 106:609–614CrossRef Bartek J Jr, Sjåvik K, Kristiansson H, Ståhl F, Fornbe I, Förander P, Jakola AS (2017) Predictors of recurrence and complications after chronic subdural hematoma surgery: a population-based study. World Neurosurg 106:609–614CrossRef
6.
Zurück zum Zitat Brennan PM, Kolias AG, Joannides AJ, Shapey J, Marcus HJ, Gregson BA, Grover PJ, Hutchinson PJ, Coulter IC (2017) The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom. J Neurosurg 127(4):732–739CrossRef Brennan PM, Kolias AG, Joannides AJ, Shapey J, Marcus HJ, Gregson BA, Grover PJ, Hutchinson PJ, Coulter IC (2017) The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom. J Neurosurg 127(4):732–739CrossRef
7.
Zurück zum Zitat Ducruet AF, Grobelny BT, Zacharia BE, Hickman ZL, DeRosa PL, Andersen KN, Sussman E, Carpenter A, Jr Connolly ES (2012) The surgical management of chronic subdural hematoma. Neurosurg Rev 35(2):155–169CrossRef Ducruet AF, Grobelny BT, Zacharia BE, Hickman ZL, DeRosa PL, Andersen KN, Sussman E, Carpenter A, Jr Connolly ES (2012) The surgical management of chronic subdural hematoma. Neurosurg Rev 35(2):155–169CrossRef
8.
Zurück zum Zitat Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ (2017) Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 14(1):108CrossRef Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ (2017) Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 14(1):108CrossRef
9.
Zurück zum Zitat Frati A, Salvati M, Mainiero F, Ippoliti F, Rocchi G, Raco A, Caroli E, Cantore G, Delfini R (2004) Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J Neurosurg 100(1):24–32CrossRef Frati A, Salvati M, Mainiero F, Ippoliti F, Rocchi G, Raco A, Caroli E, Cantore G, Delfini R (2004) Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J Neurosurg 100(1):24–32CrossRef
10.
Zurück zum Zitat Gaist D, Rodríguez LAG, Hellfritzsch M, Poulsen FR, Halle B, Hallas J, Pottegård A (2017) Association of antithrombotic drug use with subdural hematoma risk. JAMA 317(8):836–846CrossRef Gaist D, Rodríguez LAG, Hellfritzsch M, Poulsen FR, Halle B, Hallas J, Pottegård A (2017) Association of antithrombotic drug use with subdural hematoma risk. JAMA 317(8):836–846CrossRef
11.
Zurück zum Zitat Gulati S, Solheim O, Carlsen SM, Øie LR, Jensberg H, Gulati AM, Madsbu MA, Giannadakis C, Jakola AS, Salvesen Ø (2018) Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study. PLoS One 13(8):e0202575CrossRef Gulati S, Solheim O, Carlsen SM, Øie LR, Jensberg H, Gulati AM, Madsbu MA, Giannadakis C, Jakola AS, Salvesen Ø (2018) Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study. PLoS One 13(8):e0202575CrossRef
12.
Zurück zum Zitat Han MH, Ryu JI, Kim CH, Kim JM, Cheong JH, Yi HJ (2017) Predictive factors for recurrence and clinical outcomes in patients with chronic subdural hematoma. J Neurosurg 127(5):1117–1125CrossRef Han MH, Ryu JI, Kim CH, Kim JM, Cheong JH, Yi HJ (2017) Predictive factors for recurrence and clinical outcomes in patients with chronic subdural hematoma. J Neurosurg 127(5):1117–1125CrossRef
13.
Zurück zum Zitat Kolias AG, Chari A, Santarius T, Hutchinson PJ (2014) Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol 10(10):570–578CrossRef Kolias AG, Chari A, Santarius T, Hutchinson PJ (2014) Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol 10(10):570–578CrossRef
14.
Zurück zum Zitat Kung WM, Hung KS, Chiu WT, Wang YC, Lin MS (2012) Quantitative assessment of impaired postevacuation brain re-expansion in bilateral chronic subdural haematoma: possible mechanism of the higher recurrence rate. Injury 43(5):598–602CrossRef Kung WM, Hung KS, Chiu WT, Wang YC, Lin MS (2012) Quantitative assessment of impaired postevacuation brain re-expansion in bilateral chronic subdural haematoma: possible mechanism of the higher recurrence rate. Injury 43(5):598–602CrossRef
15.
Zurück zum Zitat Landriel Ibanez FA, Hem S, Ajler P, Vecchi E, Ciraolo C, Baccanelli M, Tramontano R, Knezevich F, Carizzo A (2011) A new classification of complications in neurosurgery. World Neurosurg 75(5-6):709–715CrossRef Landriel Ibanez FA, Hem S, Ajler P, Vecchi E, Ciraolo C, Baccanelli M, Tramontano R, Knezevich F, Carizzo A (2011) A new classification of complications in neurosurgery. World Neurosurg 75(5-6):709–715CrossRef
16.
Zurück zum Zitat Motiei-Langroudi R, Thomas AJ, Ascanio L, Alturki A, Papavassiliou E, Kasper EM, Arle J, Alterman RL, Ogilvy CS, Stippler M (2019) Factors predicting the need for surgery of the opposite side after unilateral evacuation of bilateral chronic subdural hematomas. Neurosurgery 85(5):648–655CrossRef Motiei-Langroudi R, Thomas AJ, Ascanio L, Alturki A, Papavassiliou E, Kasper EM, Arle J, Alterman RL, Ogilvy CS, Stippler M (2019) Factors predicting the need for surgery of the opposite side after unilateral evacuation of bilateral chronic subdural hematomas. Neurosurgery 85(5):648–655CrossRef
17.
Zurück zum Zitat Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, Sundararajan V (2011) Updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173(6):676–682CrossRef Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, Sundararajan V (2011) Updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173(6):676–682CrossRef
18.
Zurück zum Zitat Rocchi G, Caroli E, Salvati M, Delfini R (2007) Membranectomy in organized chronic subdural hematomas: indications and technical notes. Surg Neurol 67(4):374–380CrossRef Rocchi G, Caroli E, Salvati M, Delfini R (2007) Membranectomy in organized chronic subdural hematomas: indications and technical notes. Surg Neurol 67(4):374–380CrossRef
19.
Zurück zum Zitat Scheichel F, Popadic B, Ungersboeck K, Marhold F (2019) Contralateral progression after unilateral evacuation of bilateral chronic subdural hematomas: the volume relation ratio as prognostic factor? J Neurosurg 131(4):1227–1234CrossRef Scheichel F, Popadic B, Ungersboeck K, Marhold F (2019) Contralateral progression after unilateral evacuation of bilateral chronic subdural hematomas: the volume relation ratio as prognostic factor? J Neurosurg 131(4):1227–1234CrossRef
20.
Zurück zum Zitat Shen J, Gao Y, Li Q, Ge R, Wang Q, Jiang X, Shao X (2019) Risk factors predicting recurrence of bilateral chronic subdural hematomas after initial bilateral evacuation. World Neurosurg 130:e133–e139CrossRef Shen J, Gao Y, Li Q, Ge R, Wang Q, Jiang X, Shao X (2019) Risk factors predicting recurrence of bilateral chronic subdural hematomas after initial bilateral evacuation. World Neurosurg 130:e133–e139CrossRef
21.
Zurück zum Zitat Shen J, Shao X, Gao Y, Li Q, Ge R, Wang Q, Zhou W, Jiang X (2019) Risk factors for contralateral hematoma progression after unilateral evacuation of bilateral chronic subdural hematomas. World Neurosurg 126:e773–e778CrossRef Shen J, Shao X, Gao Y, Li Q, Ge R, Wang Q, Zhou W, Jiang X (2019) Risk factors for contralateral hematoma progression after unilateral evacuation of bilateral chronic subdural hematomas. World Neurosurg 126:e773–e778CrossRef
22.
Zurück zum Zitat Sjåvik K, Bartek J Jr, Sagberg LM, Henriksen ML, Gulati S, Ståhl FL, Kristiansson H, Solheim O, Förander P, Jakola AS (2017) Assessment of drainage techniques for evacuation of chronic subdural hematoma: a consecutive population-based comparative cohort study. J Neurosurg. https://doi.org/10.3171/2016.12.JNS161713 Sjåvik K, Bartek J Jr, Sagberg LM, Henriksen ML, Gulati S, Ståhl FL, Kristiansson H, Solheim O, Förander P, Jakola AS (2017) Assessment of drainage techniques for evacuation of chronic subdural hematoma: a consecutive population-based comparative cohort study. J Neurosurg. https://​doi.​org/​10.​3171/​2016.​12.​JNS161713
23.
Zurück zum Zitat Stanisic M, Aasen AO, Pripp AH, Lindegaard KF, Ramm-Pettersen J, Lyngstadaas SP, Ivanovic J, Konglund A, Ilstad E, Sandell T, Ellingsen O, Sæhle T (2012) Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: a prospective study. Inflamm Res 61(8):845–852CrossRef Stanisic M, Aasen AO, Pripp AH, Lindegaard KF, Ramm-Pettersen J, Lyngstadaas SP, Ivanovic J, Konglund A, Ilstad E, Sandell T, Ellingsen O, Sæhle T (2012) Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: a prospective study. Inflamm Res 61(8):845–852CrossRef
24.
Zurück zum Zitat Takahashi S, Yamauchi T, Yamamura T, Ogishima T, Arai T (2018) Proposal of treatment strategies for bilateral chronic subdural hematoma based on laterality of treated hematoma. Asian J Neurosurg 13(4):1134–1139CrossRef Takahashi S, Yamauchi T, Yamamura T, Ogishima T, Arai T (2018) Proposal of treatment strategies for bilateral chronic subdural hematoma based on laterality of treated hematoma. Asian J Neurosurg 13(4):1134–1139CrossRef
25.
Zurück zum Zitat Weigel R, Schmiedek P, Krauss JK (2003) Outcome of contemporary surgery for chronic subdural haematoma: Evidence based review. J Neurol Neurosurg Psychiatry 74(7):937–943CrossRef Weigel R, Schmiedek P, Krauss JK (2003) Outcome of contemporary surgery for chronic subdural haematoma: Evidence based review. J Neurol Neurosurg Psychiatry 74(7):937–943CrossRef
Metadaten
Titel
Risk factors for need of reoperation in bilateral chronic subdural haematomas
verfasst von
Shaian Zolfaghari
Jiri Bartek Jr
Felix Djärf
San-San Wong
Isabelle Strom
Nils Ståhl
Asgeir S. Jakola
Henrietta Nittby Redebrandt
Publikationsdatum
02.04.2021
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 7/2021
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-021-04811-5

Weitere Artikel der Ausgabe 7/2021

Acta Neurochirurgica 7/2021 Zur Ausgabe

Technical Note - Neurosurgical technique evaluation

Awake surgery in sitting position for chronic subdural hematoma

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.